scholarly journals Does glossopharyngeal neuralgia need rhizotomy in neurovascular decompression surgery:a retrospective analysis of 37 cases

Author(s):  
Yu Rui ◽  
Wang Ji ◽  
Qu Chuncheng ◽  
Wei Shengcheng
2018 ◽  
Vol 29 (8) ◽  
pp. 2192-2194 ◽  
Author(s):  
Ji Wang ◽  
Rui Yu ◽  
Chuncheng Qu ◽  
Jun Jiang ◽  
Chengwei Wang ◽  
...  

2017 ◽  
Vol 160 (1) ◽  
pp. 117-123 ◽  
Author(s):  
Lei Xia ◽  
Yong-Sheng Li ◽  
Ming-Xing Liu ◽  
Jun Zhong ◽  
Ning-Ning Dou ◽  
...  

2013 ◽  
Vol 34 (3) ◽  
pp. E8 ◽  
Author(s):  
Roberto Rey-Dios ◽  
Aaron A. Cohen-Gadol

Glossopharyngeal neuralgia (GPN) is an uncommon facial pain syndrome often misdiagnosed as trigeminal neuralgia. The rarity of this condition and its overlap with other cranial nerve hyperactivity syndromes often leads to a significant delay in diagnosis. The surgical procedures with the highest rates of pain relief for GPN are rhizotomy and microvascular decompression (MVD) of cranial nerves IX and X. Neurovascular conflict at the level of the root exit zone of these cranial nerves is believed to be the cause of this pain syndrome in most cases. Vagus nerve rhizotomy is usually reserved for cases in which vascular conflict is not evident. A review of the literature reveals that although the addition of cranial nerve X rhizotomy may improve the chances of long-term pain control, this maneuver also increases the risk of permanent dysphagia and vocal cord paralysis. The risks of this procedure have to be carefully weighed against its benefits. Based on the authors' experience, careful patient selection with a thorough exploratory operation most often leads to identification of the site of vascular conflict, obviating the need for cranial nerve X rhizotomy.


2018 ◽  
Vol 117 ◽  
pp. 339-343 ◽  
Author(s):  
Dhivya Palanisamy ◽  
Miyatani Kyosuke ◽  
Yamada Yasuhiro ◽  
Kawase Tsukasa ◽  
Yoko Kato

2020 ◽  
Vol 29 (4) ◽  
pp. e152
Author(s):  
Christopher J. Hadley ◽  
Anant Dixit ◽  
John Kunkel ◽  
Alex E. White ◽  
Michael G. Ciccotti ◽  
...  

2021 ◽  
Vol 5 (2) ◽  
pp. 296-301
Author(s):  
Christopher J. Hadley ◽  
Anant Dixit ◽  
John Kunkel ◽  
Alex E. White ◽  
Michael G. Ciccotti ◽  
...  

2021 ◽  
pp. 5-11
Author(s):  
Victor Souza ◽  
Maria Passerini ◽  
Bianca Sobral ◽  
Vinicius Baiardi ◽  
Hilton Junior

Introduction Glossopharyngeal neuralgia is a rare syndrome characterized by paroxysms of unilateral and severe stabbing pain occurring in the nerve’s distribution. Although other neuralgias are well described in the medical literature, glossopharyngeal neuralgia and its physiopathology are not. The vascular compression at the nerve root entry zone is the primary explanation for the disease. The first-line treatment is pharmacological, including carbamazepine, oxcarbazepine, and gabapentin. Surgical treatment is offered to medication-refractory patients, and microvascular decompression surgery has the best outcomes. Objective To investigate the pathophysiological and clinical aspects of the different presentations of glossopharyngeal neuralgia. Method: A systematic review of the literature including case reports and clinical trials, was done. Results A search of the literature yielded 31 papers that regarded glossopharyngeal neuralgia or its variants. Eight of these reports regarded vagoglossopharyngeal neuralgia. Seven regarded the glossopharyngeal neuralgia followed by or caused by another disease. Conclusion Glossopharyngeal neuralgia is a rare disease and requires further studies on its mechanism and clinical assessment; the physician needs to know how to distinguish it from its variants and underlying causes.


Sign in / Sign up

Export Citation Format

Share Document